Expression of Ca2+-independent and Ca2+-dependent phospholipases A2 and cyclooxygenases in human melanocytes and malignant melanoma cell lines

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 10, 2008, Pages 635-642

  Scuderi, Mariagrazia Rita ^a   Anfuso, Carmelina Daniela ^a   Lupo, Gabriella ^a   Motta, Carla ^a   Romeo, Loriana ^a   Guerra, Liliana ^b   Cappellani, Alessandro ^a   Ragusa, Nicola ^a   Cantarella, Giuseppina ^a   Alberghina, Mario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Cyclooxygenase; Eicosanoid; Human melanoma; Melanocyte; Phospholipase A2

Indexed keywords

CALCIUM CHANNEL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ICOSANOID; MESSENGER RNA; PHOSPHOLIPASE A2;

ARTICLE; CANCER INVASION; CELL CULTURE; CELL FRACTIONATION; CELL LINE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; ELECTROPORATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA CELL; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYTOSOL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROUP II PHOSPHOLIPASES A2; HUMANS; MAP KINASE KINASE 1; MELANOCYTES; MELANOMA; ORGANELLES; PHOSPHOLIPASES A2; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE INHIBITORS;

EID: 52049091243     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.07.007     Document Type: Article

References (41)

1. Tang D.G., Diglio C.A., and Honn K.V. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a post-transcriptional, protein kinase C- and cytoskeleton-dependent process. Cancer Res. 54 (1994) 1119-1129
2. Olaso E., Salado C., Egilegor E., Gutierrez V., Santisteban A., Sancho-Bru P., et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37 (2003) 674-685
3. Reich R., and Martin G.R. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins 51 (1996) 1-17
4. Nie D., Lamberti M., Zacharek A., Li L., Szekeres K., Tang K., et al. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem. Biophys. Res. Commun. 267 (2000) 245-251
5. Winer I., Normolle D.P., Shureiqi I., Sondak V.K., Johnson T., Su L., and Brenner D.E. Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis. Melanoma Res. 12 (2002) 429-434
6. 2. J. Lipid Mediat. Cell Signal. 12 (1995) 87-117
7. 2 isoforms: a perspective. Cell Signal. 15 (2003) 637-665
8. 2: structure and function. Biochim. Biophys. Acta 1488 (2000) 28-39
9. 2. Prog. Nucleic Acid Res. Mol. Biol. 67 (2001) 1-33
10. 2 through arachidonic acid mobilization is involved in Caco-2 cell growth. J. Cell Physiol. 193 (2002) 293-298
11. Balsinde J., and Dennis E.A. Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J. Biol. Chem. 271 (1996) 31937-31941
12. 2 gene multiple enzymes with distinct properties from a single gene. Eur. J. Biochem. 262 (1999) 575-585
13. 2 in membranes and arachidonic acid liberation in zymosan-stimulated macrophage-like P388D1 cells. Biochem. Pharmacol. 63 (2002) 1969-1977
14. 2 activity by a novel PKC isoform in ventricular myocytes. Am. J. Physiol. Cell Physiol. 283 (2002) C1621-1626
15. 2 in bovine retina capillary pericytes. Biochim. Biophys. Acta 1686 (2004) 125-138
16. 2) attenuates mitochondrial phospholipid loss and is cardioprotective. Biochem. J. 362 (2002) 23-32
17. 2 activity modulates the release of cytochrome c from mitochondria and influences the permeability transition. J. Biol. Chem. 281 (2006) 6931-6939
18. 2. J. Biol. Chem. 275 (2000) 9937-9945
19. Zambruno G., Marchisio P.C., Melchioni A., Bondanza S., Cancedda R., and De Luca M. Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes. J. Cell Sci. 105 (1993) 179-190
20. Orsulic S., Li Y., Soslow R.A., Vitale-Cross L.A., Gutkind J.S., and Varmus H.E. Induction of ovaric cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1 (2002) 53-62
21. Desai B.N., Myers B.R., and Schreiber S.L. FKB12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. PNAS 99 (2002) 4319-4324
22. 2 and MAP kinases by oxidized low-density lipoproteins in immortalized GP8.39 endothelial cells. Biochim. Biophys. Acta 1753 (2005) 135-150
23. Nystrom M.L., McCulloch D., Weinreb P.H., Violette S.M., Speight P.M., Marshall J.F., Hart I.R., and Thomas G.J. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion. Cancer Res. 66 (2006) 10833-10842
24. 2 protein expression through activation of PKCalpha and the MAPK/ERK cascade. J. Lipid Res. 48 (2007) 782-793
25. 2 by amyloid β(25-35) peptide in bovine retina pericytes. Biochim. Biophys. Acta 1733 (2005) 172-186
26. 2 mutations in neuroblastoma, melanoma and colon-cancer cell lines. Int. J. Cancer 72 (1997) 337-339
27. 2 plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 282 (2002) G586-597
28. 2 in human melanoma tumor cells. J. Immunol. 156 (1996) 201-207
29. 2 regulation of arachidonic acid mobilization. FEBS Lett. 531 (2002) 2-6
30. 2 in prostate cancer. Cancer Lett. 240 (2006) 9-16
31. 2. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 175-189
32. Bao S., Bohrer A., Ramanadham S., Jin W., Zhang S., and Turk J. Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J. Biol. Chem. 281 (2006) 187-198
33. Denkert C., Kobel M., Berger S., Siegert A., Leclere A., Trefzer U., et al. Expression of cyclooxygenase-2 in human malignant melanoma. Cancer Res. 61 (2001) 303-308
34. Higashi Y., Kanekura T., and Kanzaki T. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression. Int. J. Cancer 86 (2000) 667-671
35. Nicolaou A., Estdale S.E., Tsatmali M., Herrero D.P., and Thody A.J. Prostaglandin production by melanocytic cells and the effect of alpha-melanocyte stimulating hormone. FEBS Lett. 570 (2004) 223-226
36. Goulet A.C., Einsphar J.G., Alberts D.S., Beas A., Burk C., Bhattacharyya A., Bangert J., Harmon J.M., Fujiwara H., Koki A., and Nelson M.A. Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression. Cancer Biol. Ther. 2 (2003) 713-718
37. Kuzbicki L., Sarnecka A., and Chwirot B.W. Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression. Melanoma Res. 16 (2006) 29-36
38. Tsuji S., Tsujii M., Kawano S., and Hori M. Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis. J. Exp. Clin. Cancer Res. 20 (2001) 117-129
39. Pisano C., Ottaiano A., Tatangelo F., Di Bonito M., Falanga M., Iaffaioli V.R., et al. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas. Anticancer Res. 25 (2005) 2065-2068
40. Koumas L., and Phipps R.P. Differential COX localization and PG release in Thy-1+ and Thy-1- human female reproductive tract fibroblasts. Am. J. Physiol. Cell Physiol. 283 (2002) C599-C608
41. Peng J.P., Su C.Y., Chang H.C., Chai C.Y., and Hung W.C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the hypopharynx. Hum. Pathol. 33 (2002) 100-104